MANGALAM GLOBAL ENTERPRISE
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.70 | 1.40 | 0.92 | 1.65 | 2.31 |
| CEPS(Rs) | 0.77 | 0.80 | 0.57 | 0.28 | 0.31 |
| DPS(Rs) | 0.01 | 0.02 | 0.02 | 1.00 | 1.00 |
| Book NAV/Share(Rs) | 6.12 | 9.63 | 8.15 | 29.19 | 27.43 |
| Tax Rate(%) | 26.53 | 10.71 | 20.99 | 19.66 | 20.24 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 1.97 | 1.96 | 2.05 | 0.97 | 1.20 |
| EBIT Margin(%) | 2.71 | 2.64 | 2.16 | 1.22 | 1.40 |
| Pre Tax Margin(%) | 1.38 | 1.23 | 1.13 | 0.35 | 0.62 |
| PAT Margin (%) | 1.01 | 1.10 | 0.89 | 0.28 | 0.49 |
| Cash Profit Margin (%) | 1.11 | 1.26 | 1.11 | 0.58 | 0.80 |
| Performance Ratios | |||||
| ROA(%) | 4.84 | 4.89 | 3.67 | 1.47 | 2.67 |
| ROE(%) | 13.58 | 16.05 | 13.44 | 4.99 | 7.40 |
| ROCE(%) | 16.16 | 14.40 | 11.47 | 8.01 | 8.81 |
| Asset Turnover(x) | 4.78 | 4.45 | 4.12 | 5.20 | 5.41 |
| Sales/Fixed Asset(x) | 31.61 | 26.57 | 25.10 | 31.35 | 22.01 |
| Working Capital/Sales(x) | 15.86 | 18.40 | 27.85 | 20.85 | 26.02 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.03 | 0.04 | 0.04 | 0.03 | 0.05 |
| Receivable days | 36.04 | 38.11 | 36.94 | 25.27 | 22.65 |
| Inventory Days | 16.68 | 17.14 | 23.97 | 20.07 | 8.54 |
| Payable days | 5.78 | 8.93 | 14.86 | 10.75 | 6.52 |
| Valuation Parameters | |||||
| PER(x) | 21.61 | 6.92 | 15.62 | 12.74 | 1.96 |
| PCE(x) | 19.66 | 12.06 | 12.54 | 74.41 | 14.79 |
| Price/Book(x) | 2.48 | 2.01 | 1.76 | 7.22 | 1.65 |
| Yield(%) | 0.07 | 0.10 | 0.14 | 0.47 | 2.18 |
| EV/Net Sales(x) | 0.31 | 0.26 | 0.29 | 0.52 | 0.21 |
| EV/Core EBITDA(x) | 10.67 | 9.42 | 11.92 | 39.55 | 12.54 |
| EV/EBIT(x) | 11.46 | 9.67 | 13.35 | 42.21 | 15.28 |
| EV/CE(x) | 1.67 | 1.38 | 1.22 | 3.29 | 1.08 |
| M Cap / Sales | 0.22 | 0.15 | 0.14 | 0.43 | 0.12 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 24.09 | 29.09 | 11.36 | 33.24 | 64.99 |
| Core EBITDA Growth(%) | 33.21 | 44.82 | 106.22 | 1.98 | 20.04 |
| EBIT Growth(%) | 27.19 | 58.03 | 96.58 | 16.39 | 24.89 |
| PAT Growth(%) | 14.32 | 59.17 | 251.25 | -23.72 | 91.73 |
| EPS Growth(%) | -49.99 | 52.96 | -44.58 | -28.39 | 18.15 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 1.11 | 1.45 | 1.96 | 1.60 | 1.76 |
| Current Ratio(x) | 1.43 | 1.41 | 1.18 | 1.37 | 1.27 |
| Quick Ratio(x) | 1.12 | 0.98 | 0.94 | 0.66 | 1.10 |
| Interest Cover(x) | 2.03 | 1.87 | 2.09 | 1.40 | 1.79 |
| Total Debt/Mcap(x) | 0.45 | 0.71 | 1.10 | 0.22 | 1.06 |
Compare Financial Ratios of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹569.5 Cr | 0.7% | 13.1% | NA | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,267.8 Cr | -0.8% | -3.8% | -16.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,584.5 Cr | -2% | -8.8% | 3.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,119.4 Cr | -1.5% | -6.5% | -23.7% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,421.2 Cr | 1.2% | -3.8% | -31.6% | Stock Analytics | |
| INDO US BIOTECH | ₹339.7 Cr | 5.8% | 11.2% | -20.5% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | 0.7% |
13.1% |
|
| SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses
